Literature DB >> 1877601

Risk of death from Alzheimer's disease in a community population of older persons.

D A Evans1, L A Smith, P A Scherr, M S Albert, H H Funkenstein, L E Hebert.   

Abstract

A random sample of 467 persons over age 65 years from the population of an urban US community, stratified by age, sex, and performance on a brief memory test, underwent clinical evaluation for dementing illness in 1982-1984. Of these persons, 134 had probable Alzheimer's disease, 166 had possible Alzheimer's disease, and 167 had no evidence of Alzheimer's disease. Over a median follow-up period of 4.9 years following evaluation, 165 (35%) died. Overall, persons with probable Alzheimer's disease had a relative risk of death 1.44 (95% confidence interval (Cl) 1.05-1.96) times that of the unaffected. Level of cognitive impairment and the presence of cachexia upon physical examination both strongly and independently modified risk of death. Among those with probable Alzheimer's disease, mortality for those with mild or moderate cognitive impairment and no evidence of cachexia was comparable to that of the unaffected. However, among those with probable Alzheimer's disease and either severe cognitive impairment or cachexia, the risk of death was substantially higher. Persons with probable Alzheimer's disease who had both severe cognitive impairment and clear cachexia had a risk of death 4.60 (95% Cl 1.63-13.1) times that of unaffected persons.

Entities:  

Mesh:

Year:  1991        PMID: 1877601     DOI: 10.1093/oxfordjournals.aje.a116102

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  13 in total

1.  Predictors of mortality in patients with Alzheimer's disease living in nursing homes.

Authors:  G Gambassi; F Landi; K L Lapane; A Sgadari; V Mor; R Bernabei
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-07       Impact factor: 10.154

2.  Practice patterns in the evaluation and management of dementia by primary care residents, primary care physicians, and geriatricians.

Authors:  Saira Baloch; Shannon Burton Moss; Rajasree Nair; Leslie Tingle
Journal:  Proc (Bayl Univ Med Cent)       Date:  2010-04

3.  Baseline differences and trajectories of change for deceased, placed, and community residing Alzheimer disease patients.

Authors:  Richard Schulz; Bozena Zdaniuk; Steven H Belle; Sara J Czaja; Henry Michael Arrighi; Arthur S Zbrozek
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Apr-Jun       Impact factor: 2.703

4.  How many dementia cases in France and Europe? Alternative projections and scenarios 2010-2050.

Authors:  T Mura; J-F Dartigues; C Berr
Journal:  Eur J Neurol       Date:  2009-10-01       Impact factor: 6.089

5.  Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

Authors:  R Brookmeyer; S Gray; C Kawas
Journal:  Am J Public Health       Date:  1998-09       Impact factor: 9.308

6.  Low blood pressure and five-year mortality in a Stockholm cohort of the very old: possible confounding by cognitive impairment and other factors.

Authors:  Z Guo; M Viitanen; B Winblad
Journal:  Am J Public Health       Date:  1997-04       Impact factor: 9.308

7.  Deaths attributable to Alzheimer's disease in the United States.

Authors:  D C Ewbank
Journal:  Am J Public Health       Date:  1999-01       Impact factor: 9.308

8.  Survival in Alzheimer disease: a multiethnic, population-based study of incident cases.

Authors:  E P Helzner; N Scarmeas; S Cosentino; M X Tang; N Schupf; Y Stern
Journal:  Neurology       Date:  2008-11-04       Impact factor: 9.910

9.  Biracial population study of mortality in mild cognitive impairment and Alzheimer disease.

Authors:  Robert S Wilson; Neelum T Aggarwal; Lisa L Barnes; Julia L Bienias; Carlos F Mendes de Leon; Denis A Evans
Journal:  Arch Neurol       Date:  2009-06

10.  Significant effect of APOE epsilon 4 genotype on the risk of dementia in Alzheimer's disease and mortality in persons with Down syndrome.

Authors:  V P Prasher; S G Sajith; S D Rees; A Patel; S Tewari; N Schupf; W B Zigman
Journal:  Int J Geriatr Psychiatry       Date:  2008-11       Impact factor: 3.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.